Brazil’s Hypera buys Latam OTC products from Sanofi for $190 million

SAO PAULO (Reuters) – Brazilian pharmaceutical company Hypera SA has acquired 12 over-the-counter (OTC) and prescription brands in Latin America from France’s Sanofi SA for $190.3 million, the company said in a securties filing.


By Paula Later via Reuters


Read full article here

Share This

Chamber Updates Stay connected with Chamber activities